A new simple, sensitive, rapid and accurate gradient reversed-phase high-performance liquid chromatography with photodiode array detector (RP-HPLC-DAD) was developed and validated for simultaneous analysis of Metronidazole (MNZ), Spiramycin (SPY), Diloxanidefuroate (DIX) and Cliquinol (CLQ) using statistical experimental design. Initially, a resolution V fractional factorial design was used in order to screen five independent factors: the column temperature (°C), pH, phosphate buffer concentration (mM), flow rate (ml/min) and the initial fraction of mobile phase B (%). pH, flow rate and initial fraction of mobile phase B were identified as significant, using analysis of variance. The optimum conditions of separation determined with the aid of central composite design were: (1) initial mobile phase concentration: phosphate buffer/methanol (50/ 50, v/v), (2) phosphate buffer concentration (50 mM), (3) pH (4.72), (4) column temperature 30°C and (5) mobile phase flow rate (0.8 ml min −1 ). Excellent linearity was observed for all of the standard calibration curves, and the correlation coefficients were above 0.9999. Limits of detection for all of the analyzed compounds ranged between 0.02 and 0.11 μg ml −1 ; limits of quantitation ranged between 0.06 and 0.33 μg ml −1 . The proposed method showed good prediction ability.
Introduction
Metronidazole (MNZ) is a 5-nitroimidazole derivative with activity against anaerobic bacteria and protozoa. MNZ is used in the treatment of susceptible protozoal infections, treatment and prophylaxis of anaerobic bacterial infections and specific bacterial infections (1) .
Diloxanidefuroate (DIX) and Diiodohydroxyquinoline, also known as Cliquoinol (CLQ) are a dichloroacetamide derivative and a halogenated hydroxyquinoline, respectively. They are luminal amoebicides acting principally in the bowel lumen and are used in the treatment of intestinal amoebiasis; however, diloxanidefuroate is usually preferred over diiodohydroxyquinoline for treatment of children. They are given alone in the treatment of asymptomatic cyst passers or with an amoebicide that acts in the tissues, such as MNZ, in patients with invasive amoebiasis (1) .
Spiramycin (SPY) is a macrolide antibacterial that is used similarly to erythromycin in the treatment of susceptible bacterial infections. It has also been used, alone or in combination with MNZ, in the protozoal infections, cryptosporidiosis and toxoplasmosis (1) . The combination of MNZ and SPY has been developed on the basis of the complementarity of the antibacterial activity of both compounds in vitro on the range of bacteria involved in dental infections, including facultative and strict anaerobes, along with the possibility of a synergic activity on some anaerobic strains (2, 3) .
The four drugs were determined separately using various techniques and in combination with other drugs. MNZ was determined individually by short-wavelength NIR spectroscopy (4), voltammetry (5, 6) , NMR spectrometry (7), gas chromatography and HPLC methods either alone (8) (9) (10) or in the presence of its metabolites (11) or in the presence of its degradation product (12) , in addition to its mixture with other drugs (13) (14) (15) (16) (17) (18) (19) . DIX was determined individually by colorimetric method (20) , in the presence of its degradation products by chemometric-assisted spectrophotometric methods (21) , by derivative technique, derivative ratio, TLC-densitometry (22) and HPLC (22, 23) , in addition to its mixture with other drugs (24) (25) (26) (27) (28) . CLQ was determined alone using HPLC (29) (30) (31) or in combination with MNZ (28, 32) . SPY was determined individually in plasma and tissue including radioactive assay (33) , microbiological analysis (34, 35) and HPLC with ultraviolet detection (36, 37) or tandem mass detection (38) or in combination with MNZ (39) (40) (41) (42) . But the literature survey revealed that there is no published method for the simultaneous chromatographic determination of MNZ, DIX, CLQ and SPY in pharmaceutical dosage forms.
Developing and optimizing a HPLC method is a complex procedure that requires simultaneous determination of several factors (e.g. type and composition of the organic phase, column temperature, flow rate, pH and type of the stationary phase). In case only one factor needs to be optimized, a simple univariate procedure is performed. However, usually two or more factors are studied. This can be done using either univariate or multivariate optimization strategies. The traditional approach was studying the influence of the corresponding factors by changing one variable at a time (OVAT) approach, whilst keeping the others constant. The OVAT methods were proved inefficient because the global optimum might not be found, and the found optimal conditions might depend on the starting conditions (43) .
On the other hand, a multivariate approach varies several factors simultaneously. An experimental design is an experimental set-up that allows studying simultaneously a number of factors in a predefined number of experiments. Roughly, experimental designs can be divided into screening designs (e.g. full factorial, fractional factorial and Plackett-Burman designs), response surface designs and mixture designs. Screening designs allow screening a relatively large number of factors in a relatively small number of experiments. They are used to identify the most influencing factors. The factors are evaluated at two levels in these designs. Response surface designs are used to find the optimal levels of the most important factors, which are selected from a screening design approach. In these designs, factors are examined at least at three levels. The optimal conditions are usually derived from response surfaces build with the design results. Mixture designs are response surface designs used when all factors examined are mixture-related, i.e. factors representing the fraction of a given component in a mixture. Examples of such factors are the organic modifiers in a mobile phase in chromatography, or the excipients in a tablet or another pharmaceutical formulation. Which designs finally are applied depends on the number and type of factors to be examined, on the purpose of their use, and on the preference of the analyst (44).
The aim of this work is to develop a validated reversed-phase high-performance liquid chromatography method for the simultaneous separation of MNZ, DIX, CLQ and SPY simultaneously. The significance of the studied factors was evaluated with the aid of a resolution (V) fractional factorial design (FFD) whilst the optimum chromatographic conditions were estimated by a central composite design (CCD) using a mathematical global optimization approach (Derringer's desirability function). Finally, the proposed method was tested for linearity, specificity, inter and intra-day precision, accuracy, robustness (using experimental design). Three commercial pharmaceutical dosage forms containing the separated compounds were analyzed in order to check the validity of the proposed method.
Experimental
The HPLC (Hitachi LaChrome Elite, Tokyo, Japan) instrument was equipped with a model series L-2000 organizer box, L-2300 column oven, L-2130 pump with built in degasser, Rheodyne 7725i injector with a 20 μl loop and a L-2455 photodiode array detector (DAD), separation and quantitation were made on a 250 × 4. 
Chromatographic conditions
The best composition of the mobile phase through gradient elution was prepared by using 50 mM phosphate buffer and adjusted with 1 M HCl to a pH of (4.27 ± 0.01) as mobile phase A-methanol as mobile phase B (50:50 v/v), The mobile phase B was initially started at 50% then it was gradient up to 60% over 3 min, then it was gradient up to 80% over 2 min (5 min), then it was gradient up to 90% over 1 min (6 min), then it was gradient up to 95% over 1 min (7 min), then it was isocratically held for 8 min (15 min). Finally, the column was equilibrated for 10 min at the initial mobile phase composition before each analysis. The flow rate was maintained at 0.8 ml min −1 at all phases of the gradient run. The mobile phase was filtered through a 0.45-µm disposable filter (Milliopore Milford, MA). All determinations were performed at 30°C. The injection volume was 20 μl. Quantitation was achieved with UV detection at 242 nm based on peak area.
Experimental designs and statistical analysis
Screening experiments with the aid of FFD Before starting an optimization procedure, it is important to identify the crucial factors affecting the quality of the derived outcomes. In the present study the significance of five independent factors on the quality of the separation was investigated using a FFD. FFD approaches are particularly effective and versatile to reduce the number of trial experiments in the development of HPLC procedures (45) . Five factors were chosen for this study the column temperature (°C), pH, phosphate buffer concentration (mM), flow rate (ml min −1 ) and the initial fraction of mobile phase B (%). Use of FFD kept the number of experiments low based on the assumption that interaction effects between three or more parameters are small compared to main and two-variable interaction effects. Thus, it is possible to select a fraction of the full factorial design and omit several combinations of parameters from experimental plan (46) . The number of experiments in FFD is given by 2 k−p , were k is the number of variables and p is the whole number that indicates how fractionated the experimental design will be. When p is 0, the experimental design is full. In this study, a resolution V design was used and a total of 16 experiments (2 5-1 ) were carried out in randomized run order. The mathematical model associated with the design consists of main and possible interaction effects (Equation (1)):
where n is the number of factors, X is the factor examined, Y is the measured response and β 0 , β i , β ij represent the coefficients for each main or interaction effect. By using this design, the five experimental variables were tested at two different levels: column temperature (X 1 ) at 25 and 35°C, pH (X 2 ) at 2.5 and 5, phosphate buffer concentration (X 3 ) at 30 and 50 mM, flow rate (X 4 ) at 0.8 and 1.2 ml min −1 and initial fraction of mobile phase B (X 5 ) at 40 and 50%. Three responses were taken into consideration and they were chromatographic parameters that described the system suitability, such as the resolution between the two critically separated peaks as MNZ and SPY (Res (MNZ-SPY)), the column efficiencies of the DIX (N (DIX)) peak, finally, the tailing factors for the marginally tailed peak SPY (TF (SPY)) ( Table I) .
Optimization using CCD
From the results of the FFD, a CCD was built using only the variables that were found significant. CCD can be applied to optimize an HPLC separation by gaining better understanding of factor's main and interaction effects. The CCD was built from the full factorial design 2 k to which star and center points were added. The length of the arms of the star determined the number of levels and the shape of the experimental design. The CCD was completed by addition of center points. The total number N of experiments with k factors is: N = 2 k +2k + c. The first term is related to the full factorial design, the second to the star points and the third to the center point. The length of the arms of the star (α) played a major role for the appearance of the CCD. If α ≠ 1, each variable will assume five levels (−α, −1, 0, +1, +α) (47) . In the present study, a rotatable CCD (RCCD) was used. In this type of design the star points are equal to ±(2 k ) 1/4 (α = 1.68). The information is equally generated from all directions, i.e. the variance of the estimated responses is the same at all points on a sphere centered at the origin. Six center point replications were done to consider the experimental errors. Then, the 20 experiments (N = 8 + 6 + 6) were done in random order. The factors that were found significant in the screening study were: pH, flow rate and %B (initial fraction of mobile phase B). The selected responses were Res (MNZ-SPY), N (DIX) and TF (SPY) ( Table II) . The quadratic mathematical model for the three independent factors is given in the following equation: 0  1  2  3  1 2  1 3  2 3   11  2  22  2  33  2 where A, B and C are the factors examined, Y is the measured response, β 1 , β 2 and β 3 represent the linear regression coefficients, β 12 , β 13 and β 23 represent the interaction regression coefficients and β 11 , β 22 and β 33 represent the quadratic regression coefficients. Surface plots were developed using the fitted quadratic polynomial equation and were used to locate the points of maximum HPLC response for each analyte in the considered domain. The optimal conditions were obtained by choosing the best optimum value for each the HPLC response.
Statistical tools
The experimental data processing required for the HPLC response calculation, the fitting procedures and the corresponding statistical analysis were performed by using the Microsoft Excel 2010 software. Work on experimental design, response surfaces and contour diagrams, was performed by Design Expert Version 7 (Stat-Ease Inc., Minneapolis, MN).
Preparation of standard and calibration solutions
Stock standard solutions were prepared by dissolving (25 mg) of MNZ, SPY, DIX and CLQ separately in (50 ml) with methanol. The dissolution was made with the help of ultrasonic bath for about (15 min). The calibration standard working solutions were prepared by dilution of the stock standard solutions with the initial mobile phase composition to reach the concentration ranges of (1-
respectively. Triplicate 20 μl injections were made for each drug concentration level and chromatographed under the conditions described above with diode array detection. The peak area of each drug concentration level was plotted against the corresponding concentration to obtain the calibration graph of each drug. All stock and working standard solutions were kept away from light to avoid photodegradation.
Assay mixtures preparation
Seven synthetic mixtures were prepared by accurately transferring aliquot portions of each drug standard stock solution to a series of 10 ml volumetric flasks and completing to the volume with the initial mobile phase composition to obtain the final injected amount ratios. All mixtures were chromatographed under the specified chromatographic conditions and the concentrations of each drug were calculated from the corresponding regression equation. accurately weighed and dissolved in methanol via ultra-sonication for 15 min. The solution was cooled then transferred and diluted to a 100 ml in a volumetric flask with methanol, respectively. The solutions were filtered through a 0.45-µm disposable filter (Milliopore, Milford, MA) before use. Further dilutions of the prepared solutions were carried out using the initial mobile phase composition to reach the linearity range specified for each drug in the calibration graphs. The general procedures described under calibration were followed and the concentration of each drug was calculated.
Pharmaceutical dosage form preparation

Results
Screening experiments with the aid of FFD
The results obtained by the statistical analysis of variance (ANOVA) of the studied factors and effects are given in Table III . The results showed that the factors: pH (X 2 ), flow rate (X 4 ) and B% (X 5 ) had significant effects on all of the selected responses. Two level interactions between the selected factors showed relatively low significant effects (Table III) . Adjusted R 2 was >0.999.
Optimization using CCD
The results obtained by the statistical ANOVA of the studied factors and effects is given in Table IV . The results showed that B% (factor B) again had the most important effect on Res (MNZ-SPY). Whilst pH (factor A) and Flow rate (factor C) had the most significant effects on N (DIX) and TF (SPY). Quadratic terms showed relatively lower significant effects. A 2 and B 2 showed significant effect on Res (MNZ-SPY), while C 2 showed significant effect on N (DIX). Also, factor interactions had significant effects especially on TF (SPY) as the model of this response was linear (quadratic terms were not significant) (Table IV) . In perturbation Figure 1a shows that %B (factor B) had the most important effect on Res (MNZ-SPY). Increasing levels of B resulted in an increase in the investigated resolution. The rest of the examined factors (pH and flow rate) had significant effect on N (DIX) and TF (SPY) (Figure 1b and c) . In Figure 1b and c, N (DIX) and TF (SPY) values decreased as the levels of factors A and C increased. Small curvature in most perturbation plots indicates reduced quadratic significance. Response surfaces are shown in Figure 2 . Analytically, the interaction effects of pH and %B are illustrated in Figure 2a . It shows that Res (MNZ-SPY) vary in a nearly linear descending pattern, whereas N (DIX) and TF (SPY) exhibit a linear ascending order. Figure 2b illustrates the response surfaces for the interaction effect of pH and mobile phase flow rate. In Figure 2b values of all responses (Res (MNZ-SPY), N (DIX) and TF (SPY)) increase when both factors decrease and all responses exhibit a linear ascending order. The interaction effects of %B and flow rate are illustrated in Figure 2c . It shows that N (DIX) and TF (SPY) exhibit a linear ascending order, on the other hand the value of Res (MNZ-SPY) increases when %B increases and the flow rate of the mobile phase decreases. The small curvature of all response surfaces (Figure 2) indicates that all factors contributed nearly individually in the separation process.
Graphical and mathematical methods were used for global optimization of the separation conditions. The graphical method was based on contour overlay plots (Figure 3 ). These plots represents the alteration of all selected responses against two independent factors, whilst keeping the rest at a constant level. The optimum experimental conditions were defined by different colored area Ω in Figure 3 . In this area the tailing factor of SPY peak was kept at 0.9-1.1 between the critical values of 0.8-1.2, giving the maximum possible resolution for the critical pair of separation (Res (MNZ-SPY)) and keeping the column efficiency of separation of DIX peak as high as possible. The optimum conditions identified with the aid of overlay contour plots were in the following area: pH from 2.96 to 4.49, %B from 47.94 to 50% and flow rate from 0.8 to 0.91.
The response surfaces (Figure 4 ) of the desirability function shows that high desirability values were obtained by increasing %B and decreasing the flow rate, while a compromise should be done for optimum pH conditions. Investigation of model predictability the difference between predicted and observed (actual) values were assessed by calculating the prediction error (Equation 3):
Observed Predicted Predicted 100 3
The percentage prediction error was equal to 0.056, 1.28 and 0.024 for Res (MNZ-SPY), N (DIX) and TF (SPY), respectively.
The developed method has been applied for the separation of MNZ, SPY, DIX and CLQ. These drugs were separated under the previously described gradient elution procedure. Under these conditions the four drugs were completely separated before 15 min. The retention time of MNZ, SPY, DIX and CLQ was approximately 4.5, 8.3, 11.1 and 14.8 min, respectively.
The proposed method offers high sensitivity as about 0.02, 0.11, 0.09 and 0.07 µg ml −1 of MNZ, SPY, DIX and CLQ could be accurately detected, respectively. 
Bold values indicate that the independent factor has insignificant effect to the selected response.
a Value close to 1 shows perfect fit to Equation (1).
Analysis of pharmaceutical product
The proposed method was applied to the determination of MNZ, SPY, DIX and CLQ in their commercial dosage forms. Five replicate determinations were made. Satisfactory results were obtained for each compound in a good agreement with the labeled claims. The mean percentage of declared contents (n = 7) was found to be 101. 10 
Validation of the method
Linearity
The linearity of the proposed method was evaluated by analyzing a series of different concentrations of each compound. Seven concentrations were chosen, ranging between 1-20, 1-20, 0.4-7 and 0.3-5 µg ml −1 for MNZ, SPY, DIX and CLQ. The assay was performed according to experimental conditions previously established. Each concentration was repeated three times. The linearity of the calibration graphs and adherence of the system to Beer's law was validated by the high value of the correlation coefficient 0.9999 for all the determined drugs, and low value of yintercept.
Precision
Repeatability of the method was tested by choosing three concentration levels for each compound and analyzing them as described under experimental section at nominal conditions and they were repeated three times within a day (intra-day precision). While, intermediate precision was tested by analyzing the three concentration levels for each compound, three times on different three days (inter-day precision).
The mean relative standard deviation values for MNZ, SPY, DIX and CLQ were found to be 0.34, 0.66, 0.45 and 0.77 for repeatability (intra-day precision) and 0.24, 0.56, 0.82 and 0.76 for intermediate precision (inter-day precision), respectively, indicating high precision of the method.
Range
The calibration range was established through consideration of the practical range necessary, according to each compound concentration present in pharmaceutical product, to give accurate, precise and linear results. The calibration range of each compound is as mentioned above in the linearity section.
Detection and quantitation limits
According to ICH recommendations (48) , the approach based on the S.D. of the response and the slope was used for determining the detection and quantitation limits (Equation 4, 5).
where σ is the SD of response and S is the slope of the calibration line.
The theoretical values were assessed practically and the method has a detection limit of 0.02, 0.11, 0.09 and 0.07 µg ml ), (b) pH and Flow rate for the three measured responses (%B was kept constant at 45%) and (c) %B and flow rate for the three measured responses (pH was kept constant at 3.75).
Robustness
The insensitivity of the HPLC method to minor changes in the optimized experimental conditions was demonstrated. None of change in the column temperature, pH, flow rate and phosphate buffer concentration caused significant changes in resolution of the critically separated peak (Res (MNZ-SPY)), the tailing factor of the marginally tailed peak SPY and the column efficiency of the separated peaks.
Selectivity
Method selectivity was achieved by preparing different mixtures of MNZ, SPY, DIX and CLQ within the linearity range concentration. The laboratory prepared mixtures were analyzed according to the previous procedure described under the proposed method. The mean percentage recovery values obtained for MNZ, SPY, DIX and CLQ were 100.17, 100.03, 100.18 and 100.18%, respectively. The results obtained indicating high selectivity of the proposed method for determination of MNZ, SPY, DIX and CLQ.
Accuracy
The accuracy study was performed for the three commercial pharmaceutical formulations. The resulting mixtures were assayed and the mean percentage recoveries and their standard deviation results were obtained for MNZ, SPY, DIX and CLQ and compared with the expected results.
The mean percentage recovery values obtained for MNZ, SPY, DIX and CLQ were 99.98, 99.89, 100.18 and 100.02%, respectively. In all the cases, the results showed a fairly good accuracy of the method. Consequently, the excipients in the pharmaceutical formulations do not interfere with the analysis of the latter compounds in their formulations.
Stability
The stability of MNZ, SPY, DIX and CLQ standard solutions in the mobile phase were evaluated by leaving the standard solutions in tightly capped volumetric flasks, protected from light, on a laboratory bench and in the refrigerator. The studied compound solutions in mobile phase exhibited no chromatographic changes for 24 h when kept at room temperature and for 3 days when stored refrigerated at 4°C.
Discussion
The developed method aimed to develop a gradient HPLC method for the separation of MNZ, SPY, DIX and CLQ. These drugs have different structures, so it was not possible to separate them in the same run using isocratic conditions. Consequently, these drugs were separated using gradient elution procedure. Several trials were done to separate the analyzed compounds. The lower cost methanol was the organic modifier of choice giving well-resolved symmetrical narrow peaks with minimal baseline shift. The analyzed drugs have different detection wavelengths. The use of DAD helped in choosing the suitable wavelength for detection of the four drugs. Besides, the narrow informative range of SPY (210-250 nm) was considered. So, the four drugs were detected at 242 nm where high absorptivity and minimum noise was observed.
Screening experiments with the aid of FFD
The insignificant terms were eliminated from the model through backward elimination process. An independent factor had significant effect on a given response when it had a P < 0.05.
Although temperature (X 1 ) and buffer concentration (X 3 ) showed significant effects for Res (MNZ-SPY) and N (DIX), respectively, the effect of each factor was relatively low and could be neglected. Analytically, the initial fraction of mobile phase B (X 5 ) mainly affected the resolution of the critically separated MNZ and SPY peaks. Also, pH (X 2 ) and flow rate (X 4 ) mainly affected the column efficiency of the lowest resolved DIX peak. Similarly, pH (X 2 ) and flow rate (X 4 ) mainly affected the tailing factor of the marginally tailed SPY peak. The high adjusted R 2 value revealed good fit of the experimental data. Optimization of the three significant factors needed to be done to identify the optimum chromatographic conditions. While the insignificant factors temperature (X 1 ) and buffer concentration (X 3 ) were kept constant at 30°C and 40 mM, respectively.
Optimization using CCD
Perturbation plots were presented to show the effect of each factor on a specific response with all other factors held constant at reference point (49) . Curvature or slope steepness indicates sensitiveness to a specific factor.
Response surfaces were presented to show the response pattern for each two factor interaction. Based on the results of Figure 2 , optimization of the separation conditions could be concluded. The criteria for that optimization will be based on: maximum resolution between peaks, highest column efficiency in separation and lowest tailing factor for the marginally tailed peak. The analysis of response surfaces conclude the need to make a compromise between the optimums of each response separately.
The optimum conditions resulted from overlay contour plots were finely tunned mathematically. The mathematical method was estimated by Derringer's desirability function (49) (Equation 6):
where pi is the weight of the response, n is the number of response and d i the individual desirability function of each response. In the present study all pi values were set equal to 1. Derringer's desirability function (D) can take values from 0 to 1. A value close to unity indicates that the combination closely near the global optimum (49) . Based on the results of Figure 4 , the following conditions were found optimum: pH 4.27, initial fraction of mobile phase B 50% and mobile phase flow rate 0.8 ml min . These conditions had a desirability value of 0.662. The chromatogram obtained by these conditions is shown in Figure 5 .
The investigation of model predictability indicated small difference between predicted and observed response values. The optimized method offers a good resolution of MNZ, SPY, DIX and CLQ with high sensitivity and reasonable retention time.
Analysis of pharmaceutical product
The proposed method was able to remove the interferences of the other excipients present in the pharmaceutical products and MNZ, SPY, DIX and CLQ were assessed with a high percentage of recovery.
Validation of the method
The performance of the proposed method was validated according to ICH guidelines. The linearity of the calibration graphs was tested by the high value of the correlation coefficient and small value of yintercept; additionally, the RSD values for inter-day and intra-day repeatability indicated the precision of the method. The selectivity and accuracy of the method were assessed; the results showed that the proposed methods were able to analyze MNZ, SPY, DIX and CLQ from other endogenous interferences (degradants and excipients) with high selectivity and accuracy. Moreover, the stability of the analytical solution was checked; it was found that MNZ, SPY, DIX and CLQ solutions were stable.
Conclusion
A systematic and practical approach was utilized to develop an efficient and robust HPLC method to MNZ, SPY, DIX and CLQ in pharmaceutical dosage forms.
Multivariate regression analysis was successfully employed to effectively screen the main effects of factors that significantly affected the resolution, column efficiency and tailing of the critical peaks. Three factors that were determined to significantly affect the peaks were then analyzed to determine their interactions and quadratic effects with the CCD in conjunction with response surface methodology.
A desirability function was applied to determine the optimum conditions that could accurately quantify the analyzed drugs with low limits of detection and quantitation. The optimum conditions were validated according to ICH guidelines. The method was 
